Neuralink’s current trial, named the The PRIME Study, is aimed at providing individuals with quadriplegia the ability to ...
Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results